Concord Drugs Ltd — Important, 14-02-2026: Company Update

The company has announced a board meeting to consider and approve the financial results for the quarter and half-year. The board will also discuss a proposal to raise funds by issuing up to 5,000,000 new equity shares. Additionally, a strategic expansion plan for its manufacturing unit, involving an investment of approximately 12 Cr, will be reviewed. This expansion is projected to increase production capacity by 20% and contribute significantly to future revenue growth, according to management's outlook. This signals upcoming financial disclosures and potential growth drivers.